Simple and efficient construction method of DNA-protein oriented coupling model
Through visible photocatalytic strategy and oximetization coupling reaction, a site-specific DNA-protein coupling model was constructed, which solved the problem of lack of site selectivity and complex chemical synthesis in the prior art, and achieved efficient and simple DNA- The construction of protein coupling model has promoted the study of DNA damage repair mechanism.
Patent Information
- Application Number
- CN202411138401.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-19
- Publication Date
- 2024-12-03
AI Technical Summary
It is difficult to construct a DNA-protein coupling model with site specificity in the prior art, especially in in vitro studies. Traditional methods lack site selectivity and complex chemical synthesis processes, which limits the study of DNA damage repair mechanisms.
The visible photocatalysis strategy is used to direct the lysine structure of the target site of the protein, and a hydrolyzed and stable DNA-protein covalent coupling product is formed through the oximetization coupling reaction, realizing directed covalent coupling under physiological conditions. Coupon.
It has achieved efficient and simple construction of site-specific DNA-protein coupling models, improved experimental efficiency and reliability of results, and is suitable for the study of different proteins, providing important tools for the study of DNA damage repair mechanisms.
Smart Images

Figure CN119060116A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of chemical biology and medicinal chemistry, and specifically relates to a simple and efficient method for constructing a DNA-protein directional coupling model. Background Art
[0002] DNA damage is closely related to disease. The heterocyclic base sequence in the DNA double helix structure constitutes the genetic code that drives the operation of all organisms. The correctness and stability of the coding sequence are crucial for the expression of functional mRNA and proteins in cells. Cells are affected by a variety of environmental factors, and various endogenous and exogenous threats cause irreversible damage to DNA in cells, leading to the occurrence of diseases such as cancer, neurodegenerative diseases and autoimmune diseases.
[0003] DNA-protein cross-links (DPCs) are a type of complex and special DNA damage with high heterogeneity. Different types of DPCs vary depending on the structure of DNA, the type of protein and the method of chemical binding.
[0004] In the chromatin structure, DNA with about 145 base pairs is wrapped around an octamer composed of histones H2A, H2B, H3 and H4 to form a nucleosome. The N-terminal tail of histones has a large number of lysines, which are easily reacted with a variety of endogenous DNA structures containing aldehyde groups to form Schiff base-type DNA-histone covalent couples (DHCs) that are reversible by hydrolysis but have a relatively long half-life. At present, the research on the repair mechanism of DNA-protein coupled damage is not very sufficient. The design, construction and characterization of damage models are necessary links in the research of related types of DPC repair mechanisms. Therefore, constructing a variety of in vitro research models and improving the accuracy of characterization methods are key issues that need to be urgently addressed in the study of DNA damage repair.
[0005] There are currently two main ways to obtain DHC in vitro: (1) using reducing agents (such as NaBH4, NaBH3CN, etc.) to reduce the C=N bond to a CN bond to form a stable DHC. However, this strategy not only requires the use of a controlled reducing agent, but also lacks site selectivity. The resulting product is often a mixture, which is not applicable in studies with site specificity; (2) using the oximation coupling method developed by Tretyakova et al., which uses a rapid bioorthogonal approach to prepare 5fC-H3 DHC that is hydrolytically stable, structurally similar to endogenous DHC, and site-selective. Oximation coupling utilizes the reaction of carbonyl compounds with ammonia oxides to form a stable RC=NOR bond, thereby avoiding the hydrolytic stability problem of Schiff bases. However, this method requires multi-step chemical synthesis and solid-phase peptide synthesis, which is complicated and time-consuming, and sortase-mediated ligation requires a conserved LPXTG motif, which limits its application in other histones (SSPujari, M.Wu, J.Thomforde, ZAWang, C.Chao, NM Olson, L.Erber, WCKPomerantz, P.Cole and NYTretyakova, Angew Chem Int Ed Engl, 2021, 60, 26489-26494.; SSPujari, Y.Zhang, S.Ji, MDDistefano and NYTretyakova, Chem Commun (Camb), 2018, 54, 6296-6299.). Summary of the invention
[0006] The present invention aims to provide a method for constructing a site-specific DNA-protein coupling model in vitro. The present invention utilizes a visible light catalytic strategy to carry out directional functionalization of lysine structural analogs on the target site of the protein, thereby achieving directional covalent coupling of protein and DNA under physiological conditions.
[0007] The present invention specifically adopts the following technical solutions:
[0008] The present invention provides a simple and efficient method for constructing a DNA-protein directional coupling model, comprising:
[0009] Step 1: Directly install the lysine derivative into the cysteine site obtained by mutation of the wild-type protein;
[0010] The lysine residues of the wild-type protein will form a hydrolytically reversible Schiff base type DNA-protein covalent coupling (DPC) product with DNA but with a long half-life, causing DNA damage. If the wild-type protein does not contain cysteine (or the mutation of cysteine does not affect the function of the wild protein), but contains lysine, the method of the present invention can be used to mutate the lysine at the target site in the wild-type protein into cysteine, and then the lysine derivative can be installed in a directed manner at the cysteine site obtained by the mutation, and the lysine derivative will form a hydrolytically stable endogenous DPC structural analog with DNA.
[0011] In a further embodiment, the wild-type protein is histone H4.
[0012] Step 1 specifically includes the following:
[0013] Step 1.1: Reduce and convert the cysteine side chain group -CH2-CH2-SH of the wild-type protein after mutation to -CH=CH2; specifically, dithiothreitol (DTT) and 2,5-dibromohexadiamide (DBHDA) can be used to reduce and convert the side chain group -CH2-CH2-SH of the cysteine after mutation of the wild-type protein, respectively. When DTT is used for reduction, the amount of DTT is 100 equivalents, and the reaction is shaken at room temperature for 4 hours. When DBHDA is used for conversion, the amount of DBHDA is 100 equivalents, and the reaction is shaken at 37°C for 4 hours.
[0014] Step 1.2: Bpin (compound 1), catechol and the product of step 1.1 are subjected to visible light catalytic reaction under the action of Ru(bpm)3Cl2 catalyst, and the -CH=CH2 structure in the residue is functionalized with -OxyK-Boc, and the -OxyK-Boc structure is -CH2-CH2-CH2-CH2-O-NH-Boc; in the catalytic reaction, the amounts of Bpin, catechol and Ru(bpm)3Cl2 are 1000 equivalents, 100 equivalents and 10 equivalents, respectively, and the catalytic reaction is carried out at 4°C in a reaction system of pH 7.5 for 40 minutes.
[0015] The Bpin is synthesized by the following method: 2-(3-bromopropyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane and potassium tert-butoxide are added to a dichloromethane solution of tert-butyl hydroxycarbamate, and the mixture is stirred overnight at room temperature to obtain Bpin; in the reaction, the molar ratio of tert-butyl hydroxycarbamate to 2-(3-bromopropyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane and potassium tert-butoxide is 75:83:225.
[0016] Step 1.3: The product in step 1.2 is reacted with trifluoroacetic acid (TFA) and HCl respectively to remove -Boc; specifically, the product in step 1.2 is dissolved in a 50% TFA aqueous solution to a final concentration of 1 mg / mL, and the reaction is carried out at room temperature for 2 hours under the protection of an inert gas. Then, HCl is added to the reaction system, and the reaction is shaken for 1 hour under the protection of an inert gas.
[0017] Step 2: The oligonucleotide is reacted with the product of step 1 through an oximation coupling reaction to obtain a DNA-protein covalent coupling product.
[0018] Step 2 specifically includes:
[0019] The oligonucleotide with a phospho-α,β-unsaturated aldehyde (PUA) group at the 3′ end was incubated with the product of step 1 at 37°C for 20 hours to obtain a DNA-protein covalent coupling product. The molar ratio of the oligonucleotide with a PUA group at the 3′ end to the product of step 1 was 1:2.
[0020] The beneficial effects of the present invention are:
[0021] 1. High efficiency and simplicity: The present invention uses visible light catalysis strategy to install OxyK to specific sites on proteins, and then obtains hydrolysis-stable DPC products through oximation coupling reaction, and verifies its site specificity and structural integrity through LC-MS / MS and in vitro enzyme repair tests. Figure 1 As shown. The present invention realizes site-selective chemical modification of proteins with lysine derivatives under mild conditions, and constructs an in vitro research model of directional coupling of DNA and protein, stable in hydrolysis, and highly similar to the chemical structure of endogenous DPC. The method has simple steps and rapid reaction, which helps to improve experimental efficiency and reduce the requirements for experimental equipment and operations.
[0022] 2. Wide applicability: The method of the present invention does not rely on specific enzyme cleavage sites and is applicable to all proteins that do not contain cysteine (or cysteine mutation does not affect protein function) and contain lysine. Traditional methods usually require specific motifs or multi-step chemical synthesis, while the method of the present invention has a wider applicability and can meet the research needs of different proteins.
[0023] 3. Stability and reliability: The DNA-protein covalent coupling structure (DHC) formed by the oximation reaction has a high degree of hydrolytic stability, ensuring stability and reliability in in vitro studies. This stable coupling structure is conducive to further research on biochemical effects and repair mechanisms, and improves the reproducibility and credibility of experimental results.
[0024] 4. Research value: This invention provides a method for efficiently constructing a site-specific DHC model, which provides an important tool for studying the mechanism of DNA damage repair. The DHC model prepared by this method can better simulate endogenous DNA-protein coupling damage, helping scientists to gain a deeper understanding of the role and mechanism of DPCs in DNA damage repair.
[0025] 5. Other applications: This strategy has potential application value in the fields of biotechnology and drug development. By chemically modifying proteins at specific sites, new biomarkers and drug targets can be developed to promote the diagnosis and treatment of diseases related to DNA damage and repair. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 Schematic diagram of the strategy for visible-light-driven DPC construction.
[0027] Figure 2 For the product Bpin 1 H NMR spectrum.
[0028] Figure 3 For the product Bpin 13 C NMR spectrum.
[0029] Figure 4 A comparison chart of the amino acid sequences of H4K20C and H4.
[0030] Figure 5 FPLC purification of H4K20C (A) and SDS-PAGE purity detection (B). Lanes 16 to 26 in (B) correspond to A / 16 to A / 26 in the red frame of (A), indicating different subsamples.
[0031] Figure 6 MALDI-ToF-MS spectrum characterization of H4K20C.
[0032] Figure 7 This is a diagram of the synthesis method of H4-Dha20.
[0033] Figure 8 H4-Dha 20 LC-MS spectra of (original spectrum (upper) and deconvoluted spectrum (lower)).
[0034] Fig. 9 H4-OxyK 20 -Boc synthesis method diagram.
[0035] Fig.10 H4-OxyK 20 -LC-MS spectra of Boc (original spectrum (upper) and deconvoluted spectrum (lower)).
[0036] Fig.11 H4-OxyK 20 Synthesis method diagram.
[0037] Fig.12 H4-OxyK 20 LC-MS spectrum (A) and LC-MS / MS spectrum (B) of.
[0038] Fig.13 H4-OxyK 20 SDS-PAGE (20%) detection chart.
[0039] Fig.14 3′-PUA-OxyK 20 -H4's oximation coupling synthesis method.
[0040] Fig.15 10% SDS-PAGE gel to detect 3′-PUA and H4-Oxy K 20 coupling reaction.
[0041] Fig.16 Characterization of 3′-PUA-OxyK on 10% SDS-PAGE gel 20 -H4 integrity.
[0042] Fig.17 Characterization of 3′-PUA-OxyK for LC-MS / MS 20 -H4 preprocessing method diagram.
[0043] Fig.18 3′-PUA-OxyK 20 LC-MS / MS spectrum of -H4.
[0044] Fig.19 3′-PUA-OxyK after hybridization 20 -H4 was incubated with trypsin overnight at room temperature.
[0045] Fig. 20 Schematic diagram of APE1 excision repair site (top); 10% SDS-PAGE image showing APE1 to 3′-PUA-OxyK without trypsin digestion 20 -H4 excision efficiency (middle); 20% urea-PAGE shows the effect of APE1 on 3′-PUA-OxyK after trypsin digestion 20 -H4 excision efficiency (bottom).
[0046] Fig.21 APE1 to 3′-PUA-OxyK 20 -H4 repair efficiency. DETAILED DESCRIPTION
[0047] In order to make the purpose, technical solution and advantages of the present invention clearer, the technical solution in the embodiment of the present invention will be clearly described below in conjunction with the drawings in the embodiment of the present invention. Obviously, the described embodiment is a part of the embodiment of the present invention, not all the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0048] OxyK: A chemically modified lysine K (-NH2) derivative (RO-NH2) that can react with aldehyde groups to form a hydrolytically stable coupling structure;
[0049] DHC: (DNA-histone cross-links) A coupling body formed by covalent connection between DNA and histone;
[0050] APE1: a key enzyme for repairing DNA abasic sites, used in the present invention to study the in vitro repair mechanism of DHC;
[0051] 3′-PUA: 3′-phospho-α,β-unsaturated aldehyde, a DNA damage product containing an aldehyde group, which can form Schiff base type DPCs (DNA-protein cross-links) with lysine side chains in histones, which are reversible in hydrolysis but have a long half-life.
[0052] Oximation coupling: a fast, efficient and bioorthogonal chemical reaction that generates a hydrolytically stable covalent bond similar to the natural Schiff base structure by reacting -O-NH2 with R-CHO;
[0053] AP site: abasic site, a form of DNA damage, usually formed by the removal of DNA bases;
[0054] Proteinase K: a broad-spectrum proteolytic enzyme used for protein degradation, used in the present invention to verify the integrity of DPC;
[0055] TDP1: Tyrosine-DNA phosphodiesterase 1, an enzyme that can cleave the 3′-terminal phosphodiester bond, is used in the present invention to release the intact histone H4 from the DHC conjugate.
[0056] Example 1
[0057] 1. Synthesis of compound 1 (tert-butyl(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propoxy)carbamate)
[0058]
[0059] 2-(3-bromopropyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane (217.3 mg, 0.83 mmol, 184 μL) and potassium tert-butoxide (252.8 mg, 2.25 mmol) were added to a solution of tert-butyl hydroxycarbamate (100 mg, 0.75 mmol) in DCM (2.0 mL), and the reaction was stirred overnight at room temperature. After the reaction was completed, the precipitate was filtered and the product was purified using a silica gel column (n-hexane: ethyl acetate = 5: 1) to obtain a colorless oily liquid product with a yield of 91%.
[0060] NMR data: 1 H NMR (400MHz, CDCl3) δ7.53 (s, 0H), 3.74 (t, J = 6.4Hz, 1H), 1.76-1.57 (m, 1H), 1.41 (s, 5H), 1.18 (s, 6H), 0.75 (t, J = 7.4Hz, 1H). 13 C NMR (126MHz, CDCl3)δ156.75,83.15,81.27,78.07,28.23,24.74,22.19,19.54. Figure 2 and Figure 3 The obtained compound 1 is also called Bpin.
[0061] High resolution mass spectrometry: HRMS (ESI-TOF) m / z [C 14 H 28 BNO5+H] + :calculated 302.2139,found302.2175.
[0062] 2. Expression and Purification of H4K20C
[0063] H4K20C indicates that the 20th amino acid residue of H4 (the first amino acid residue from the second S residue) mutates from K to C. The amino acid sequence of H4 is shown in SEQ ID NO: 1. The amino acid sequence of H4K20C is shown in SEQ ID NO: 2. The amino acid comparison of H4 and H4K20C is shown in Figure 4The expression and purification of H4K20C refer to the published literature (Yang, K.; Prasse, C.; Greenberg, MME effect of Histone Lysine Methylation on DNA Lesion Reactivity in Nucleosome Core Particles. Chem Res Toxicol 2019, 32 (5), 910-916.), and the specific process is as follows.
[0064] (1) Expression of H4K20C
[0065] 1) 20 μL of E. coli competent cells BL21(DE3)pLysS (purchased from Invitrogen) were transfected with 1 μg of pET histone expression plasmid and plated on 2×YT (formula: 1.6% (w / v) tryptone, 1.0% (w / v) yeast extract, 0.5% (w / v) sodium chloride) agar plates containing ampicillin (100 μg / mL) and chloramphenicol (34 μg / mL). Incubate at 37°C overnight.
[0066] 2) Inoculate a colony on the 2×YT agar plate in 1) into a pre-culture tube containing 20 mL of 2×YT medium (containing ampicillin (100 μg / mL) and chloramphenicol (25 μg / mL)), and incubate on a shaker at 37°C overnight.
[0067] 3) Add the culture solution in the pre-culture tube to 2 L of 2×YT medium (containing ampicillin (100 μg / mL) and chloramphenicol (25 μg / mL)). Incubate at 37°C in a shaking incubator.
[0068] 4) When OD 600 When the value reached 0.6, IPTG (final concentration 0.5 mM) was added to induce expression.
[0069] 5) After 4 hours, the cells were collected in a 50 mL centrifuge tube at room temperature, quickly frozen in liquid nitrogen, and then stored at -80°C.
[0070] (2) Preparation of inclusion bodies
[0071] 1) The frozen cells in (1) were re-thawed in a washing buffer (formula: 50 mM Tris·HCl (pH=7), 100 mM sodium chloride, 1 mM EDTA, 10 mM β-mercaptoethanol, 0.2 mM phenylmethylsulfonyl fluoride) (1 g cells / 10 mL washing buffer) and intermittently ultrasonicated in an ice bath (30 seconds on, 20 seconds off, for a total of 40 minutes).
[0072] 2) The cells were disrupted by ultrasound and centrifuged (12000 g, 4° C., 20 minutes); the supernatant was discarded and the solid precipitate was resuspended in a washing buffer containing 1% Triton X-100.
[0073] 3) Repeat the previous step twice, and repeat twice using the washing buffer without TritonX-100, collect the solid, and freeze it at -80°C.
[0074] (3) FPLC purification of H4K20C
[0075] 1) Add 3 mL of DMSO to the frozen inclusion bodies in (2) to help them reconstitute in extraction buffer (formula: 20 mM Tris·HCl, pH 7, 10 mM DTT, 7 M Gdn·HCl), and incubate on a shaker at room temperature for 2.5 hours.
[0076] 2) Centrifuge (12000 g, 4°C, 20 minutes); collect the supernatant and filter with 0.45 μm filter paper.
[0077] 3) Using FPLC, gel filtration and ion exchange chromatography were performed under denaturing conditions to purify H4K20C, and then the purified H4K20C was detected by SDS-PAGE gel. Figure 5 The MALDI-ToF-MS spectrum of H4K20C is shown in Figure 6 As shown, MALDI-ToF-MS cal 11212, MALDI-ToF-MS ob It is 11212.
[0078] According to the above method, 2L IPTG-induced BL21(DE3)pLysS cell culture medium containing pET histone expression plasmid was expressed and purified to obtain 8.5g of high-purity histone H4K20C.
[0079] 3. H4-Dha 20 Synthesis
[0080] like Figure 7As shown, histone H4K20C (8 mg) was completely dissolved in NaPi buffer (100 mM NaPi (phosphate buffer), 3 M Gdn·HCl (acting as a solubilizing protein), pH 8, 1.6 mL), treated with DTT (100 equivalents, 250 mM, 295 μL) to reduce disulfide bonds, and shaken at 10 rpm at room temperature for 4 hours. The reaction solution was dialyzed in deoxygenated water (1 L) overnight (4°C) and for 4 hours (4°C). The protein concentration was determined by Nanodrop, and then 2,5-dibromohexadiamide (DBHDA, 100 equivalents, 500 mM, DMSO) was added to the reaction system and shaken at 37°C (120 rpm) for 4 hours. The small molecules in the reaction system were removed by dialysis again, and the product was obtained as a white solid after lyophilization. H4-Dha 20 The concentration and yield were calculated by Nanodrop assay, and the molecular weight of the product was determined by LC-MS analysis.
[0081] H4-Dha 20 The LC-MS spectrum is as follows Figure 8 As shown, LC-MS cal 11177, LC-MS ob It is 11177.
[0082] 4.H4-OxyK 20 Photocatalytic synthesis of -Boc
[0083] According to the reported conditions (B.Josephson, C.Fehl, PGIsenegger, S.Nadal, THWright, AWJPoh, BJBower, AMGiltrap, L.Chen, C.Batchelor-McAuley, G.Roper, O.Arisa, JBISap, A.Kawamura, AJBaldwin, S.Mohammed, RGCompton, V.Gouverneur and B.G.Davis, Nature, 2020, 585, 530-537.), 500 equivalents of Bpin molecules were added to NH4OAc buffer (0.5M, 3MGdn·HCl, pH 6) in a nitrogen protection environment, and the catechol-Ru(bpm)3Cl2 system was used for visible light catalysis for 1 hour. However, the crude reaction solution was analyzed by LC-MS and the conversion rate was found to be less than 5%. Subsequently, the reaction time was extended to 2.5 hours, the amount of Bpin (compound 1) substrate was increased to 1000 equivalents, and the conversion rate was increased to 20% and 30%, respectively. Adjusting the pH value to neutral (Bpin is 1000 equivalents) and reacting for 1 hour can increase the conversion rate, and the conversion rate is increased to 79% when the pH is 7.5. However, further increasing the pH of the reaction system will cause the conversion rate to drop to 45% due to the increase in oxidation by-products. On this basis (Bpin is 1000 equivalents, pH7.5), the reaction time is shortened to 40 minutes, and the optimal conversion rate of 87% can be obtained. The specific reaction conditions are as follows:
[0084] like Fig. 9 As shown, in a glove box, H4-Dha was added to a transparent PCR tube (200 μL) containing 2.2 mg Bpin molecules (1000 equivalents). 20 (80 μg, final concentration of 1 μg / μL, 90 μM) NH4OAc solution (500 mM, 3M Gdn·HCl, pH 7.5, 78 μL). Subsequently, Ru(bpm)3Cl2 (1.2 μL, freshly prepared 66 mM aqueous solution, 10 equivalents) and catechol (1.2 μL, freshly prepared 660 mM aqueous solution, 100 equivalents) were added in sequence, and then sealed with a sealing film, removed from the glove box, and irradiated with a blue LED lamp (45 W) at 4°C for 40 minutes. The crude reaction solution was analyzed by LC-MS to determine the conversion rate. The product was purified by HPLC using a semi-preparative column (OSALysASODA, Capcell PALys C18, MG III, 5 μm, 10 mm×250 mm; 0.05% TFA in ddH2O as solvent A, 0.05% TFA in acetonitrile as solvent B). The collected product was lyophilized to obtain a white solid H4-OxyK 20-Boc. The molecular weight of the product was determined by LC-MS analysis.
[0085] H4-OxyK 20 The LC-MS spectrum of -Boc is as follows Fig.10 As shown, LC-MS cal 11352, LC-MS ob It is 11352.
[0086] 5.H4-OxyK 20 Synthesis
[0087] like Fig.11 As shown, in a glove box, 80 μg H4-OxyK 20 -Boc was dissolved in 50% TFA aqueous solution to a final concentration of 1 mg / mL, and the reaction was carried out at room temperature for 2 hours. Then 2N HCl (80 μL) was added to the reaction system and shaken for 1 hour under inert gas protection. The conversion rate of the reaction was determined by LC-MS analysis to be >95%.
[0088] H4-OxyK 20 The LC-MS spectra and LC-MS / MS spectra of Fig.12 As shown in A and 12B, LC-MS cal 11252, LC-MS ob is 11252. H4-OxyK 20 The SDS-PAGE (20%) detection diagram is shown in Fig.13 shown.
[0089] 6.3′-PUA-OxyK 20 Synthesis and characterization of -H4 DPC
[0090] 3′-PUA-OxyK 20 -H4 is synthesized by oximation coupling as Fig.14 As shown, specifically including:
[0091] First, oligonucleotide O1 (5 μM, 1 nmol) with a PUA group at the 3′ end was mixed with H4-OxyK 20(10 μM, 2 nmol) was mixed in NH4OAC buffer (100 mM, pH 4.6) and incubated at 37 °C for 20 hours. SDS was then added to a final concentration of 0.1%, and the pH was adjusted to about 7 using HEPES buffer (50 mM, pH 8.0), followed by heating at 90 °C for 20 minutes. After the reaction mixture was cooled, it was concentrated at 16 °C using an Amicon ultrafiltration tube with a 10 kDa cutoff. The concentrated sample (about 100 μL) was mixed with an equal volume of loading buffer (25 mM HEPES, pH 7.5, 40% glycerol, 0.2% SDS) and analyzed by 10% SDS-PAGE. The gel (12 × 8 × 0.15 cm) was run at room temperature until bromophenol blue migrated to the middle. The DPC band was cut out, crushed and mixed with elution buffer (2 mL, 0.2 M NaCl, 1 mM EDTA, 0.1% SDS) and rotated overnight at room temperature. The gel particles were removed by centrifugation. 20 The supernatant of -H4 was concentrated and replaced with HEPES buffer (20 mM, pH 7.5) at 16°C (6 times, 10-fold dilution each time).
[0092] Under the optimized conditions, the coupling efficiency is about 80% ( Fig.15 , Lane 2). Under the same conditions, wild-type H4 did not react with 3′-PUA ( Fig.15 , Lane 3), indicating that 3′-PUA-OxyK 20 -H4 only through OxyK 20 form.
[0093] 3′-PUA-OxyK 20 -H4 DHC treated with proteinase K yielded a faster migrating product with an electrophoretic mobility similar to that of 3′-PUA, which confirmed the integrity of DPC ( Fig.16 ).
[0094] 3′-PUA-OxyK was determined by SDS-PAGE (3′-PUA as reference). 20 -H4 concentration. The cross-linking sites were verified by LC-MS / MS as follows: Fig.17 As shown, excess tyrosine-DNA phosphodiesterase 1 (TDP1) was used to cleave 3′-PUA-OxyK 20 -H4 to obtain intact H4, which was then digested with trypsin and then acetylated with propionic anhydride to improve the separation of histone peptides in liquid chromatography. LC-MS / MS analysis identified K+C5H6O3 (m / z:
[0095] 114.0317) of the H4 peptide ( Fig.18 ). This result verifies the site-specificity of the conjugation strategy.
[0096] 8. APE1 to 3′-PUA-OxyK 20 -H4 fixes
[0097] Purified 3′-PUA-OxyK 20 -H4 hybridizes with the complementary strand (O2). A typical reaction system (21 μL) contains the hybridized 3′-PUA-OxyK 20 -H4 (20nM), 1× buffer (20mM Tris acetate, pH 7.9, 50mM potassium acetate, 10mM magnesium acetate, 1mM DTT) and APE1 (5nM) were incubated at 37°C. Samples were taken at different time points (0-10 minutes) and the reaction was terminated by adding an equal volume of loading buffer (50mM HEPES, pH 7.5, 40% glycerol, 0.2% SDS, 20mM EDTA) and analyzed by 10% SDS-PAGE. The gel (12×8×0.15cm) was run at constant power (5W) at room temperature until bromophenol blue migrated to the bottom third of the gel.
[0098] To study the repair of trypsin-treated DPC, the hybridized 3′-PUA-OxyK 20 -H4 was incubated with trypsin (1 μg) overnight at room temperature ( Fig.19 ), followed by the addition of PMSF (final concentration 2 mM) to terminate the reaction, and the repair reaction was performed with APE1 as described above. The gel (42 × 36 × 0.04 cm) was run at room temperature at constant power (60 W) until bromophenol blue migrated to the bottom of the gel.
[0099] The 3′-PUA-OxyK 20 The 39-nucleotide oligonucleotide of -H4 was hybridized with the complementary strand, and then excision repair was performed with APE1. The results showed that the excision repair efficiency of 3′-PUA-OxyK20-H4 DPC was greatly promoted by first digesting the cross-linked H4 with trypsin ( Fig. 20 and Fig.21 ), indicating that efficient DPC repair requires prior proteolysis of the cross-linked proteins.
[0100] Table 1. O1 and O2 sequence list
[0101]
[0102] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent replacements for some of the technical features therein. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.
Claims
1. A simple and efficient method for constructing a DNA-protein directional coupling model. It is characterized in that include: Step 1: Directly install the lysine derivative into the mutated cysteine site of the wild-type protein; The wild-type protein does not contain cysteine or the cysteine in the wild-type protein does not affect the function of the wild-type protein after mutation, and contains lysine, and the cysteine is obtained after the lysine is mutated; Step 2: The oligonucleotide is coupled with the product of step 1 through an oximation coupling reaction to obtain a structural analogue of the endogenous DNA-protein covalent coupling product.
2. A method for constructing a simple and efficient DNA-protein directional coupling model according to claim 1, It is characterized in that Step 1 specifically includes the following: Step 1.1: Mutate the cysteine side chain group -CH 2 -CH 2 -SH is reduced and converted to -CH=CH 2 ; Step 1.2: Bpin, catechol and the product of step 1.1 are reacted in Ru (bpm) 3 Cl 2 The visible light catalytic reaction is carried out under the action of the catalyst to 2 The structure is functionalized with -OxyK-Boc, wherein the -OxyK-Boc structure is -CH 2 -CH 2 -CH 2 -CH 2 -O-NH-Boc; The Bpin is synthesized by the following method: 2-(3-bromopropyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane and potassium tert-butoxide are added to a dichloromethane solution of tert-butyl hydroxycarbamate, and the mixture is stirred overnight at room temperature to obtain Bpin; Step 1.3: The product in step 1.2 was reacted with trifluoroacetic acid and HCl respectively to remove -Boc.
3. A method for constructing a simple and efficient DNA-protein directional coupling model according to claim 2, It is characterized in that In step 1.1, dithiothreitol and 2,5-dibromohexadiamide were used to treat the side chain group -CH 2 -CH 2 -SH for reduction and conversion.
4. A method for constructing a simple and efficient DNA-protein directional coupling model according to claim 3, It is characterized in that When dithiothreitol is used for reduction, the amount of dithiothreitol used is 100 equivalents, and the reaction is shaken at room temperature for 4 hours; when 2,5-dibromoadipamide is used for conversion, the amount of 2,5-dibromoadipamide used is 100 equivalents, and the reaction is shaken at 37°C for 4 hours.
5. A method for constructing a simple and efficient DNA-protein directional coupling model according to claim 2, It is characterized in that In the catalytic reaction of step 1.2, Bpin, catechol, Ru(bpm) 3 Cl 2 The dosages were 1000 equivalents, 100 equivalents, and 10 equivalents, respectively, and the catalytic reaction was carried out at 4°C for 40 minutes in a reaction system with a pH of 7.
5.
6. A method for constructing a simple and efficient DNA-protein directional coupling model according to claim 2, It is characterized in that In the synthesis of Bpin in step 1.2, the molar ratio of tert-butyl hydroxycarbamate to 2-(3-bromopropyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane and potassium tert-butoxide is 75:83:
225.
7. A method for constructing a simple and efficient DNA-protein directional coupling model according to claim 2, It is characterized in that Step 1.3 is as follows: The product in step 1.2 was dissolved in 50% trifluoroacetic acid aqueous solution to a final concentration of 1 mg / mL. The reaction was carried out at room temperature for 2 hours under inert gas protection. Then HCl was added to the reaction system and shaken for 1 hour under inert gas protection.
8. A method for constructing a simple and efficient DNA-protein directional coupling model according to claim 1, It is characterized in that Step 2 specifically includes: The oligonucleotide having a phosphate-α,β-unsaturated aldehyde group at the 3′ end is incubated with the product of step 1 at 37° C. to obtain a structural analog of the endogenous DNA-protein covalent coupling product.
9. A method for constructing a simple and efficient DNA-protein directional coupling model according to claim 8, It is characterized in that The molar ratio of the oligonucleotide with a phospho-α,β-unsaturated aldehyde group at the 3′ end to the product of step 1 is 1:
2.
10. A method for constructing a simple and efficient DNA-protein directional coupling model according to claim 1, It is characterized in that The wild-type protein is histone H4.
